Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Baxter International Inc. BAX

Healthcare  —  Medical Instruments & Supplies
23.37 (0.11) (0.47%) as of 25 Sep
Market cap
$12.2B
P/E
0.0×
S&P 500 Member Revenue Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Baxter International Inc. (BAX) Business Profile

Updated before January 2025

Company Overview

Baxter International Inc. (NYSE: BAX) is a global healthcare company headquartered in Deerfield, Illinois, United States. Founded in 1931 by Dr. Donald Baxter, the company initially focused on producing intravenous (IV) solutions and systems. Over the decades, Baxter has grown into a diversified healthcare leader, offering a wide range of products and services that address critical healthcare needs. The company operates in over 100 countries and employs approximately 50,000 people worldwide.

Baxter’s leadership team is spearheaded by its CEO, José (Joe) E. Almeida, who has been at the helm since 2016. Under his guidance, the company has focused on innovation, operational efficiency, and strategic acquisitions to drive growth. Baxter’s board of directors and executive team bring extensive experience in healthcare, pharmaceuticals, and global business operations.

Core Business Segments

Baxter operates through several core business segments, each addressing specific healthcare needs. These segments include:

1. Renal Care

Baxter is a global leader in renal care, providing products and therapies for patients with kidney disease. Key offerings include:

  • Hemodialysis (HD) Products: Machines, dialyzers, and related consumables for in-center and home hemodialysis.
  • Peritoneal Dialysis (PD) Solutions: PD systems and solutions for home-based dialysis therapy.
  • Continuous Renal Replacement Therapy (CRRT): Devices and solutions for critically ill patients with acute kidney injury.

2. Medication Delivery

This segment focuses on products that facilitate the safe and efficient delivery of medications. Key products include:

  • IV Solutions: A broad portfolio of intravenous fluids and nutritional products.
  • Infusion Systems: Smart infusion pumps and related software for medication administration.
  • Drug Reconstitution Systems: Devices that simplify the preparation and delivery of injectable drugs.

3. Pharmaceuticals

Baxter manufactures and markets a range of essential pharmaceuticals, including:

  • Anesthesia and Critical Care Drugs: Inhaled anesthetics and injectable medications for surgical and critical care settings.
  • Generic Injectables: A portfolio of generic injectable drugs used in hospitals and clinics.

4. Advanced Surgery

This segment provides innovative products for surgical care, including:

  • Hemostats and Sealants: Products that help control bleeding during surgery.
  • Surgical Staplers and Instruments: Tools designed to enhance surgical precision and efficiency.

5. Acute Therapies

Baxter offers solutions for patients with life-threatening conditions, such as:

  • Extracorporeal Membrane Oxygenation (ECMO): Devices and systems for advanced respiratory and cardiac support.
  • Sepsis Management Solutions: Products aimed at managing severe infections and related complications.

6. Nutrition

Baxter provides clinical nutrition products to support patients with specific dietary needs, including:

  • Parenteral Nutrition (PN): Intravenous feeding solutions for patients unable to consume food orally.
  • Enteral Nutrition: Nutritional products for patients requiring feeding through a tube.

Business Model

Baxter’s business model revolves around integrating innovative products and services to address critical healthcare needs. The company generates revenue through the sale of medical devices, pharmaceuticals, and consumables, as well as through service contracts and software solutions. Baxter’s approach emphasizes:

  • Global Reach: Operating in over 100 countries, Baxter leverages its extensive distribution network to serve diverse markets.
  • Customer-Centric Innovation: Developing products and solutions based on the needs of patients, healthcare providers, and payers.
  • Strategic Partnerships: Collaborating with healthcare providers, governments, and other organizations to expand access to care.

Strategic Direction

Baxter’s strategic priorities focus on driving growth, enhancing sustainability, and expanding its product portfolio. Key initiatives include:

  • Innovation: Investing in research and development to launch new products and improve existing ones.
  • Sustainability: Committing to environmental, social, and governance (ESG) goals, including reducing greenhouse gas emissions and improving access to healthcare.
  • Acquisitions and Partnerships: Pursuing strategic acquisitions to enter new markets and strengthen existing business segments.
  • Digital Transformation: Leveraging data analytics, artificial intelligence, and digital tools to enhance operational efficiency and patient outcomes.

Competitive Landscape

Baxter operates in a highly competitive healthcare industry, facing competition from both large multinational corporations and specialized companies. Key competitors include:

  • Fresenius Medical Care: A leading provider of dialysis products and services.
  • Medtronic: A global leader in medical devices and therapies.
  • B. Braun: A major player in infusion therapy and clinical nutrition.
  • Johnson & Johnson: Competes in surgical care and pharmaceuticals.
  • Pfizer: A competitor in the injectable pharmaceuticals market.

Risk Factors

Baxter faces several risks that could impact its business operations and financial performance, including:

  • Regulatory Compliance: Stringent regulations in the healthcare industry can lead to delays or additional costs.
  • Supply Chain Disruptions: Dependence on global supply chains makes Baxter vulnerable to disruptions caused by geopolitical events, natural disasters, or pandemics.
  • Market Dependence: Reliance on specific products or regions for a significant portion of revenue poses concentration risks.
  • Competition: Intense competition may pressure pricing and margins.
  • Litigation Risks: Exposure to lawsuits related to product liability or intellectual property disputes.

Recent Developments

Baxter has recently focused on expanding its product portfolio and enhancing its operational capabilities. Notable developments include:

  • Launch of New Products: Introduction of advanced dialysis machines and surgical tools.
  • Acquisitions: Acquisition of Hillrom, a global medical technology company, to strengthen its position in connected care and patient monitoring.
  • Sustainability Initiatives: Progress toward achieving carbon neutrality and reducing waste.
  • COVID-19 Response: Scaling up production of critical care products to meet increased demand during the pandemic.

Investment Considerations

Strengths:

  • Diverse Portfolio: Broad range of products and services across multiple healthcare segments.
  • Global Presence: Extensive geographic reach and strong brand recognition.
  • Innovation: Commitment to R&D and product development.
  • Strategic Acquisitions: Successful integration of acquired businesses to drive growth.

Risks:

  • Regulatory and Compliance Challenges: Potential for increased costs and delays.
  • Market Volatility: Exposure to economic and geopolitical uncertainties.
  • Competition: Pressure on pricing and market share.

Conclusion

Baxter International Inc. is a leading player in the global healthcare industry, with a strong portfolio of products and services that address critical medical needs. The company’s focus on innovation, sustainability, and strategic growth positions it well for future success. While it faces challenges such as regulatory compliance and market competition, Baxter’s strengths and strategic initiatives make it a compelling choice for investors and healthcare providers alike.